Le Lézard
Classified in: Health, Science and technology
Subject: EGV

Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptumtm for the Treatment of Schizophrenia


WASHINGTON, Nov. 10, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today the refusal of the marketing authorization application (MAA) of Fanaptumtm (oral iloperidone tablets) for the treatment of schizophrenia in adult patients in the European Union.  In July 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the Fanaptumtm MAA. Vanda requested a re-examination of the initial opinion. After considering the grounds for this request, the CHMP re-examined the opinion and confirmed the refusal of the Fanaptumtm MAA on November 9, 2017.

About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

About Fanapt®

For full U.S. Prescribing Information for Fanapt®, including indication, Boxed Warnings and Important Safety Information, visit our Web site at www.fanapt.com.

Investor Contact:
Jim Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
[email protected]

SOURCE Vanda Pharmaceuticals Inc.


These press releases may also interest you

at 19:21
SOF Week 2024: Immersive Wisdom awarded DoD-wide Five-Year sole-source $25MM ordering contract through GFY 2029 by the U.S. Air Force for groundbreaking TRL-9 No-Bandwidth and Low-Bandwidth Communications Software
Immersive Wisdom, Inc., provider of a proven TRL-9 distributed communications and ops center software platform for Denied, Degraded, Intermittent, and Limited-Bandwidth (DDIL) environments announced at SOF Week 2024 that it has been awarded a...

at 17:35
Perficient to be Acquired by EQT for Approximately $3.0 Billion
Perficient, Inc. ("Perficient" or "the Company"), a leading global digital consultancy transforming the world's largest enterprises and biggest brands, today announced that it has entered into a definitive agreement to be acquired by an affiliate of...

at 17:35
Perficient Reports First Quarter 2024 Results
Perficient, Inc. ("Perficient"), the leading global digital consultancy transforming the world's largest enterprises and biggest brands, today reported its financial results for the quarter ended March 31, 2024. Financial Highlights For the...

at 15:32
Spectacular revival of Marco Polo captivated global audience
A report from GDToday:  On the evening of May 3, 2024, the Guangzhou Opera House dazzled audiences with the performance of "Marco Polo," a captivating opera commissioned by the esteemed venue. In order to commemorate the 700th anniversary of the...

at 13:20
Community Capital's Garrett Smith Attends Milken Institute Global Conference
Garrett Smith, Founder and CEO of Community Capital Technology Inc. ("Community Capital"), will be attending the Milken Institute Global Conference ("MI Global") May 5-8, 2024 in Los Angeles. The event brings together global executives and...

at 13:16
Quarterhill Announces Sponsorship and Participation at IBTTA Technology Summit
Quarterhill Inc. ("Quarterhill" or the "Company") , a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS")...

More news about Science and technology...


News published on and distributed by: